The prognosis for older patients with acute myeloid leukemia (AML) is poor: very few achieve…
View More New treatment of acute myeloid leukemia achieves remarkable results in a disease formerly with little hope
Research implicates causative genes in osteoporosis, suggesting new targets for future therapy: Innovative functional genomics tools likely to aid discovery in other genetic diseases
Scientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate…
View More Research implicates causative genes in osteoporosis, suggesting new targets for future therapy: Innovative functional genomics tools likely to aid discovery in other genetic diseases
Molecular patterns could better predict breast cancer recurrence
The genetic and molecular make-up of individual breast tumours holds clues to how a woman’s…
View More Molecular patterns could better predict breast cancer recurrence
Researchers define cells used in bone repair
Research led by Johns Hopkins investigators has uncovered the roles of two types of cells…
View More Researchers define cells used in bone repair
Obesity linked to adverse events in children with leukemia
(HealthDay)—For children with acute lymphoblastic leukemia (ALL), obesity is associated with an increased risk for…
View More Obesity linked to adverse events in children with leukemia
Blood test shows promise for early detection of severe lung-transplant rejection: New tool that uses DNA sequencing could improve transplant outcomes and save lives
Researchers have developed a simple blood test that can detect when a newly transplanted lung…
View More Blood test shows promise for early detection of severe lung-transplant rejection: New tool that uses DNA sequencing could improve transplant outcomes and save lives
Surge protector: A novel approach to suppressing therapy-induced tumor growth and recurrence
Following up on a groundbreaking 2018 study in which BIDMC’s Dipak Panigrahy, MD, demonstrated that…
View More Surge protector: A novel approach to suppressing therapy-induced tumor growth and recurrence